Abstract
Pyrrolocytosines RX-04A-D are designed to bind to the bacterial 50S ribosomal subunit differently from currently-used antibiotics. The four analogs had broad anti-Gram-negative activity: RX-04A inhibited 94.7% of clinical Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa at 0.5-4 μg/ml, with no MICs >8 μg/ml. MICs for multi-resistant carbapenemase producers were up to two-fold higher than for control strains, with values ≥8 μg/ml for one Serratia isolate with porin and efflux lesions. mcr-1 did not affect MICs.
Original language | English |
---|---|
Pages (from-to) | e00689-18 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 62 |
Issue number | 8 |
Early online date | 18 Jun 2018 |
DOIs | |
Publication status | Published - Aug 2018 |